200,000+ products from a single source!
sales@angenechem.com
CAS No: 101-26-8 Catalog No: AG0033GW MDL No:MFCD00079283
Title | Journal |
---|---|
Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness. | Toxicology and applied pharmacology 20180701 |
Zebrafish is a predictive model for identifying compounds that protect against brain toxicity in severe acute organophosphorus intoxication. | Archives of toxicology 20170101 |
Chronic Oxidative Stress, Mitochondrial Dysfunction, Nrf2 Activation and Inflammation in the Hippocampus Accompany Heightened Systemic Inflammation and Oxidative Stress in an Animal Model of Gulf War Illness. | Frontiers in molecular neuroscience 20170101 |
Exposure to Gulf War Illness chemicals induces functional muscarinic receptor maladaptations in muscle nociceptors. | Neurotoxicology 20160501 |
Gulf War agent exposure causes impairment of long-term memory formation and neuropathological changes in a mouse model of Gulf War Illness. | PloS one 20150101 |
Persistent modification of Nav1.9 following chronic exposure to insecticides and pyridostigmine bromide. | Toxicology and applied pharmacology 20140615 |
Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models. | Disease models & mechanisms 20121101 |
Autonomic nervous system modulation affects the inflammatory immune response in mice with acute Chagas disease. | Experimental physiology 20121101 |
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. | Multiple sclerosis (Houndmills, Basingstoke, England) 20120801 |
Myasthenia gravis and endurance exercise. | American journal of physical medicine & rehabilitation 20120801 |
Gulf War illnesses are autoimmune illnesses caused by reactive oxygen species which were caused by nerve agent prophylaxis. | Medical hypotheses 20120801 |
A prospective, 1-year follow-up study of postural tachycardia syndrome. | Mayo Clinic proceedings 20120801 |
Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury. | Toxicology and applied pharmacology 20120715 |
Prolonged release matrix tablet of pyridostigmine bromide: formulation and optimization using statistical methods. | Pakistan journal of pharmaceutical sciences 20120701 |
Effects of anticholinesterase drugs on biomarkers and behavior of pumpkinseed, Lepomis gibbosus (Linnaeus, 1758). | Journal of environmental monitoring : JEM 20120501 |
[Preparation and quality control of pyridostigmine bromide orally disintegrating tablet]. | Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20120501 |
A 90 year old man with difficulty swallowing and proximal muscle weakness. | BMJ (Clinical research ed.) 20120404 |
A comparison of the efficacy of newly developed reversible inhibitors of acetylcholinesterase with commonly used pyridostigmine as pharmacological pre-treatment of soman-poisoned mice. | Basic & clinical pharmacology & toxicology 20120401 |
Myasthenia gravis: a real emergency. | International emergency nursing 20120401 |
Preparation and characterization of poly(lactic acid) nanoparticles for sustained release of pyridostigmine bromide. | Die Pharmazie 20120401 |
A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. | Journal of neurology 20120301 |
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. | Leukemia & lymphoma 20120301 |
Seronegative myasthenia gravis with bladder dysfunction. | Revue neurologique 20120301 |
Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability. | Archives of pharmacal research 20120301 |
Vincristine induced cranial neuropathy. | The Journal of the Association of Physicians of India 20120301 |
Investigation of anticholinergic and non-steroidal anti-inflammatory prodrugs which reduce chemically induced skin inflammation. | Journal of applied toxicology : JAT 20120201 |
Gulf War syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvant (ASIA). | Lupus 20120201 |
Myasthenia gravis in Jamaican children: a 12-year institutional review. | Paediatrics and international child health 20120201 |
Complex factors in the etiology of Gulf War illness: wartime exposures and risk factors in veteran subgroups. | Environmental health perspectives 20120101 |
Delayed reduction of hippocampal synaptic transmission and spines following exposure to repeated subclinical doses of organophosphorus pesticide in adult mice. | Toxicological sciences : an official journal of the Society of Toxicology 20120101 |
Pyridostigmine bromide protection against acetylcholinesterase inhibition by pesticides. | Journal of biochemical and molecular toxicology 20120101 |
Anesthesia and myasthenia gravis. | Acta anaesthesiologica Scandinavica 20120101 |
[+]-Huperzine A protects against soman toxicity in guinea pigs. | Neurochemical research 20111201 |
Proteomic CNS profile of delayed cognitive impairment in mice exposed to Gulf War agents. | Neuromolecular medicine 20111201 |
Discordant thymectomy in identical twins concordant for myasthenia gravis. | Annals of internal medicine 20111004 |
Diagnosis of congenital myasthenic syndrome with mutation of the RAPSN gene after general anaesthesia. | European journal of anaesthesiology 20111001 |
HIV-associated myasthenia gravis and impacts of HAART: one case report and a brief review. | Clinical neurology and neurosurgery 20111001 |
Treatment of myasthenia gravis: focus on pyridostigmine. | Clinical drug investigation 20111001 |
Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum. | Journal of neurochemistry 20111001 |
[Bioequivalence of pyridostigmine bromide dispersible tablets in rabbits]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111001 |
In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species. | Toxicology letters 20110925 |
Clinical profiles of Thai patients with ocular myasthenia gravis in Siriraj Hospital. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110901 |
Chemical interactions and Gulf War illnesses. | Chemico-biological interactions 20110815 |
Retention study of some cation-type compounds using bile acid sodium salts as ion pairing agents in liquid chromatography. | Biomedical chromatography : BMC 20110801 |
Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis. | Zeitschrift fur Gerontologie und Geriatrie 20110801 |
Childhood myasthenia gravis: clinical features and outcomes. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110801 |
Myasthenia gravis in a one year eight months old female child. | Journal of the Indian Medical Association 20110801 |
Autoimmune autonomic ganglionopathy after a CNS infection. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20110601 |
Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. | Pacing and clinical electrophysiology : PACE 20110601 |
Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies. | Neuromuscular disorders : NMD 20110601 |
Myasthenia gravis as a cause of head drop in Parkinson disease. | The neurologist 20110501 |
In vitro kinetic interactions of DEET, pyridostigmine and organophosphorus pesticides with human cholinesterases. | Chemico-biological interactions 20110425 |
Delayed presentation of invasive thymoma in myasthenia gravis: a case report. | Neuromuscular disorders : NMD 20110401 |
Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide. | Muscle & nerve 20110401 |
Congenital myasthenic syndrome due to homozygous CHRNE mutations: report of patients in Arabia. | Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20110301 |
Treatment for Lambert-Eaton myasthenic syndrome. | The Cochrane database of systematic reviews 20110216 |
Antiarrhythmogenic effects of a neurotoxin from the spider Phoneutria nigriventer. | Toxicon : official journal of the International Society on Toxinology 20110201 |
[Postural orthostatic tachycardia syndrome: current concepts in pathophysiology, diagnosis and therapeutic options]. | Fortschritte der Neurologie-Psychiatrie 20110201 |
A Cys-loop mutation in the Caenorhabditis elegans nicotinic receptor subunit UNC-63 impairs but does not abolish channel function. | The Journal of biological chemistry 20110128 |
Congenital myasthenic syndrome: a case report. | Genetic counseling (Geneva, Switzerland) 20110101 |
Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. | European journal of neurology 20101201 |
A predictive ligand-based Bayesian model for human drug-induced liver injury. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
Technical report: exploring the basis of congenital myasthenic syndromes in an undergraduate course, using the model organism, Caenorhabditis elegans. | Invertebrate neuroscience : IN 20101101 |
Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial. | Clinical neurology and neurosurgery 20101101 |
Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. | Hypertension (Dallas, Tex. : 1979) 20101101 |
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
Perspectives on the use of scopolamine as an adjunct treatment to enhance survival following organophosphorus nerve agent poisoning. | Military medicine 20101101 |
Visual and systemic outcomes in pediatric ocular myasthenia gravis. | American journal of ophthalmology 20101001 |
Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure. | Chemico-biological interactions 20100906 |
Cholinesterase inhibitors and stress: effects on brain muscarinic receptor density in mice. | Neurotoxicology 20100901 |
Diagnostic challenge: Myasthenia gravis in the emergency department. | Journal of the American Academy of Nurse Practitioners 20100901 |
[Course and treatment of myasthenia gravis during pregnancy]. | Der Nervenarzt 20100801 |
[Bizerine: new anticholinesterase drug with selective gastrointestinal action]. | Eksperimental'naia i klinicheskaia farmakologiia 20100801 |
Pyridostigmine-induced dystonic blepharospasm in a patient with ocular myasthenia gravis. | Movement disorders : official journal of the Movement Disorder Society 20100715 |
Gabapentin-induced exacerbation of myasthenia gravis. | Muscle & nerve 20100701 |
Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine. | Bioorganic & medicinal chemistry 20100701 |
The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine. | Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 20100601 |
Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy. | Indian journal of pediatrics 20100601 |
[Dysphagia as the sole manifestation of myasthenia gravis]. | Acta gastroenterologica Latinoamericana 20100601 |
Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008). | Journal of the American Veterinary Medical Association 20100315 |
Unsatisfactory outcomes in myasthenia gravis: influence by care providers. | Journal of neurology 20100301 |
Rituximab in the management of refractory myasthenia gravis. | Muscle & nerve 20100301 |
Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness. | Critical care medicine 20100301 |
Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications. | Bioorganic & medicinal chemistry letters 20100301 |
Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20100201 |
Post-polio syndrome: Pathophysiological hypotheses, diagnosis criteria, drug therapy. | Annals of physical and rehabilitation medicine 20100201 |
Prolonged cardioprotective effect of pyridostigmine encapsulated in liposomes. | Life sciences 20100102 |
Treatment with tertiary oximes prevents seizures and improves survival following sarin intoxication. | Journal of molecular neuroscience : MN 20100101 |
Relief from episodic weakness with pyridostigmine in paramyotonia congenita: a family study. | Muscle & nerve 20100101 |
Myasthenia gravis and return to flying status. | Aviation, space, and environmental medicine 20100101 |
Autoimmune myasthenia gravis in a ferret. | Journal of the American Veterinary Medical Association 20091215 |
Refinement of the clinical phenotype in musk-related congenital myasthenic syndromes. | Neurology 20091201 |
Pyridostigmine, working and toxicity on platelet. | The Malaysian journal of pathology 20091201 |
Gulf War illness: Effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain. | Behavioural brain research 20091105 |
Teaching NeuroImages: reversible ectropion in myasthenia gravis. | Neurology 20091020 |
Serum of patients with oral pemphigus vulgaris impairs keratinocyte wound repair in vitro: a time-lapse study on the efficacy of methylprednisolone and pyridostigmine bromide. | Oral diseases 20091001 |
Management of myasthenic conditions: nonimmune issues. | Current opinion in neurology 20091001 |
Retrospective population pharmacokinetic/pharmacodynamic analysis of pyridostigmine, a cholinesterase inhibitor, in Chinese males. | The Journal of pharmacy and pharmacology 20090901 |
Association of preeclampsia and myasthenia: a case report. | The Journal of reproductive medicine 20090901 |
Late onset generalized myasthenia gravis presenting with facial weakness and bulbar signs without extraocular muscle involvement. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20090801 |
Acetylcholine-esterase inhibitor pyridostigmine decreases T cell overactivation in patients infected by HIV. | AIDS research and human retroviruses 20090801 |
Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study. | Clinical pharmacology and therapeutics 20090701 |
Congenital myasthenic syndrome with episodic apnea. | Pediatric neurology 20090701 |
Decompensating esophoria as the presenting feature of myasthenia gravis. | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20090601 |
Vincristine induced unilateral ptosis. | Journal of pediatric hematology/oncology 20090601 |
Effect of pyridostigmine (Mestinon) on human platelet aggregation. | The Malaysian journal of pathology 20090601 |
Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis. | Archives of neurology 20090501 |
Pseudo plus-minus lid syndrome. | Archives of neurology 20090501 |
Graded response to thymectomy in children with myasthenia gravis. | Journal of child neurology 20090401 |
Toxicity and characterization of cholinesterase-inhibition induced by diisopropyl fluorophosphate in Artemia salina larvae. | Ecotoxicology and environmental safety 20090301 |
The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. | Journal of clinical gastroenterology 20090301 |
Why postprandial abdominal bloating in patients with irritable bowel syndrome does not respond to prokinetics. | The American journal of gastroenterology 20090301 |
Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. | Journal of cardiac failure 20090301 |
Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux! | Journal of critical care 20090301 |
Terbutaline in myasthenia gravis: a pilot study. | Journal of the neurological sciences 20090215 |
Repeated stress in combination with pyridostigmine Part I: long-term behavioural consequences. | Behavioural brain research 20090211 |
Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions. | The Biochemical journal 20090101 |
Membrane electrodes for the determination of pyridostigmine bromide. | Journal of AOAC International 20090101 |
An unusual presentation of myasthenia gravis. | West African journal of medicine 20090101 |
[Myasthenia gravis]. | La Revue du praticien 20081231 |
Justice delayed: acknowledging the reality of Gulf War illness. | Lancet (London, England) 20081129 |
Left ventricular long-axis function in myasthenia gravis. | Journal of neurology 20081101 |
Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. | The American journal of gastroenterology 20081001 |
Bradycardia, hypotension and bronchospasm following remifentanil-propofol in a myathenic paitent treated by pyridostigmine--a case report. | Middle East journal of anaesthesiology 20081001 |
An unusual primary presentation of myasthenia gravis. | The British journal of oral & maxillofacial surgery 20080901 |
Myasthenia gravis associated with lupus nephritis. | Lupus 20080901 |
[Integrated traditional Chinese and Western medicine in treating 31 cases of myasthenia gravis]. | Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20080901 |
Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20080801 |
Intestinal gas and bloating: effect of prokinetic stimulation. | The American journal of gastroenterology 20080801 |
Long-term outcomes of pediatric ocular myasthenia gravis. | Ophthalmology 20080701 |
Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease. | Journal of Alzheimer's disease : JAD 20080601 |
Myasthenia gravis associated with autoimmune thyroid disease: a report of two patients. | Annals of African medicine 20080601 |
Cholinergic stimulation with pyridostigmine prevents the impairment in ventricular function during mental stress in coronary artery disease patients. | International journal of cardiology 20080425 |
Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors. | Toxicology 20080418 |
Long-term clinical outcome after extended thymectomy combined postoperative high-dose steroid therapy for juvenile myasthenia gravis. | Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20080401 |
Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis. | Muscle & nerve 20080301 |
Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy. | Paediatric anaesthesia 20080301 |
In vitro metabolism and interactions of pyridostigmine bromide, N,N-diethyl-m-toluamide, and permethrin in human plasma and liver microsomal enzymes. | Xenobiotica; the fate of foreign compounds in biological systems 20080301 |
Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis. | Journal of cardiovascular electrophysiology 20080201 |
Fiberoptic endoscopic evaluation of swallowing with simultaneous Tensilon application in diagnosis and therapy of myasthenia gravis. | Journal of neurology 20080201 |
A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. | Arthritis and rheumatism 20080201 |
Myasthenia gravis: an unrecognized cause of head drop in Parkinson's disease. | Parkinsonism & related disorders 20080101 |
Myasthenia gravis crisis. | Southern medical journal 20080101 |
A cause of reversible dysphagia: an unusual presentation of myasthenia gravis. | European journal of internal medicine 20080101 |
[Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma]. | Revue neurologique 20080101 |
Extended transsternal thymectomy for myasthenia gravis: a report of 19 consecutive cases. | Acta chirurgica Belgica 20080101 |
Early onset myasthenia gravis with atypical features. | Kathmandu University medical journal (KUMJ) 20080101 |
[Diagnostics and treatment of myasthenia gravis in children]. | Przeglad lekarski 20080101 |
Protective effect of reversible cholinesterase inhibitors (tacrine, pyridostigmine) and eqbuche against VX poisoning and brain acetylcholinesterase inhibition in rats. | Acta medica (Hradec Kralove) 20080101 |
[Development of a myasthenia crisis during interferon treatment for chronic C hepatitis]. | Gastroenterologie clinique et biologique 20071201 |
[Electroacupuncture warming therapy combined with western medicine for treatment of myasthenia gravis and effect on IL-4 level in the patients]. | Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20071201 |
Treatment of botulinum toxin-induced eyelid ptosis with anticholinesterases. | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20071101 |
When the patient fails to respond to treatment: myasthenia gravis. | Practical neurology 20071101 |
Formulation design of an HPMC-based sustained release tablet for pyridostigmine bromide as a highly hygroscopic model drug and its in vivo/in vitro dissolution properties. | Drug development and industrial pharmacy 20071101 |
Latency and exposure-health associations in Gulf War veterans with early fatigue onsets: a case-control study. | Annals of epidemiology 20071001 |
Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy. | Pediatric hematology and oncology 20070901 |
Anti-musk antibody after thymectomy in a previously seropositive myasthenic child. | Neurology 20070821 |
[Successful treatment of a Lambert-Eaton myasthenic syndrome patient with 3,4-diaminopyridine]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070810 |
Is cerebral involvement an occasional feature of muscle-specific kinase antibody-positive syndrome? | European journal of neurology 20070801 |
Brugada syndrome in the presence of coronary artery disease and parasympathomimetic drug therapy. | Pacing and clinical electrophysiology : PACE 20070801 |
Myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient. | Muscle & nerve 20070701 |
Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes. | American journal of physiology. Heart and circulatory physiology 20070701 |
Myasthenia gravis in ectopic thymoma presenting as pleural masses. | Lung cancer (Amsterdam, Netherlands) 20070701 |
Post-varicella myasthenia gravis. | Singapore medical journal 20070601 |
Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning. | Archives of toxicology 20070501 |
A combination of 6 months of treatment with pyridostigmine and triweekly exercise fails to improve insulin-like growth factor-I levels in fibromyalgia, despite improvement in the acute growth hormone response to exercise. | The Journal of rheumatology 20070501 |
[Pyridostigmine in the treatment of primary orthostatic hypotension]. | Neurologia (Barcelona, Spain) 20070501 |
An investigation of acetylcholine released in skeletal muscle and protein unbound drug released in blood based on the pyridostigmine bromide (pretreatment drug) sustained-release pellets by microdialysis technique in the rabbit model. | Neuroscience letters 20070418 |
Effects of combined, multiple stressors on pyridostigmine-induced acute toxicity in rats. | Archives of toxicology 20070401 |
Dropped head as an unusual presenting sign of myasthenia gravis. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20070401 |
Concurrence of non-myasthenic symptoms with myasthenia gravis. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20070401 |
Formulation design of a highly hygroscopic drug (pyridostigmine bromide) for its hygroscopic character improvement and investigation of in vitro/in vivo dissolution properties. | Drug development and industrial pharmacy 20070401 |
Mycophenolate mofetil - as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience. | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20070301 |
Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine. | Toxicology and applied pharmacology 20070301 |
Is there still a role for edrophonium in diagnosing ocular myasthenia. | European journal of neurology 20070301 |
Factors associated with insensitivity to pyridostigmine therapy in Thai patients with ocular myasthenia gravis. | Asian Pacific journal of allergy and immunology 20070301 |
Myasthenia gravis mimicking unilateral vocal fold paralysis at presentation. | The Journal of laryngology and otology 20070201 |
Pyridostigmine in the treatment of orthostatic intolerance. | The Annals of pharmacotherapy 20070201 |
Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity. | Internal medicine journal 20070101 |
Nerve agents. | The neurologist 20070101 |
Effects of combined exposure to pyridostigmine bromide and shaker stress on acoustic startle response, pre-pulse inhibition and open field behavior in mice. | Journal of applied toxicology : JAT 20070101 |
[Anesthesia with remifentanil for thoracoscopic thymectomy in a girl with myasthenia gravis]. | Revista espanola de anestesiologia y reanimacion 20070101 |
Dropped head sign as the only symptom of myasthenia gravis. | Internal medicine (Tokyo, Japan) 20070101 |
[Criminal clozapine intoxications]. | Anesteziologiia i reanimatologiia 20070101 |
Myasthenia gravis and thymectomy: an anaesthetic approach. | Acta anaesthesiologica Belgica 20070101 |
[Treatment of Lambert-Eaton syndrome with 3,4- diaminopyridine and pyridostigmine]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101 |
An atypical course of myasthenia gravis. | Proceedings of the Western Pharmacology Society 20070101 |
Development of methods to measure humoral immune responses against selected antigens in the common marmoset (Callithrix jacchus) and the effect of pyridostigmine bromide administration. | International immunopharmacology 20061205 |
Multiple vaccine and pyridostigmine bromide interactions in the common marmoset Callithrix jacchus: immunological and endocrinological effects. | International immunopharmacology 20061205 |
[Myasthenia gravis and intestinal resection: is dehiscence likely to occur?]. | Minerva chirurgica 20061201 |
Therapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL. | Arhiv za higijenu rada i toksikologiju 20061201 |
Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon. | Archives of toxicology 20061101 |
Cerebral acetylcholine and choline contents and turnover following low-dose acetylcholinesterase inhibitors treatment in rats. | Archives of toxicology 20061101 |
Pharmacokinetics of pyridostigmine in a child with postural tachycardia syndrome. | Pediatrics 20061101 |
Coexistence of pernicious anemia and myasthenia gravis--a rare combination of autoimmune diseases in Taiwan. | Journal of the Formosan Medical Association = Taiwan yi zhi 20061101 |
Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. | Gastroenterology 20061101 |
[Bilateral paravertebral block anesthesia for thymectomy by video-assisted thoracoscopy in patients with myasthenia gravis]. | Revista espanola de anestesiologia y reanimacion 20061101 |
Persistence of CD16+/CD56-/2B4+ natural killer cells: a highly dysfunctional NK subset expanded in ocular myasthenia gravis. | Journal of neuroimmunology 20061001 |
Acetylcholinesterase inhibition in patients with orthostatic intolerance. | Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 20061001 |
Pyridostigmine, diethyltoluamide, permethrin, and stress: a double-blind, randomized, placebo-controlled trial to assess safety. | Mayo Clinic proceedings 20061001 |
Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine. | Basic & clinical pharmacology & toxicology 20061001 |
Development of miotic cross-tolerance between pyridostigmine and sarin vapor. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20061001 |
A rare combination of thymic tumor: radiologically invisible thymolipoma associated with myasthenia gravis. | Neurology India 20060901 |
Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. | Proceedings of the National Academy of Sciences of the United States of America 20060829 |
Eosinophilia, myositis, and myasthenia gravis associated with a thymoma. | Muscle & nerve 20060801 |
The 'slurp' test: bedside evaluation of bulbar muscle fatigue. | Pediatrics 20060801 |
Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug? | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20060801 |
Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. | Biochemical pharmacology 20060728 |
Available treatment options for the management of Lambert-Eaton myasthenic syndrome. | Expert opinion on pharmacotherapy 20060701 |
Neuromyotonia and myasthenia gravis in the absence of thymoma. | European journal of neurology 20060701 |
Cholinergic overstimulation supports conditioned-facilitated startle but not conditioned hyperalgesia. | Pharmacology, biochemistry, and behavior 20060701 |
Multiple vaccine and pyridostigmine interactions: effects on cognition, muscle function and health outcomes in marmosets. | Pharmacology, biochemistry, and behavior 20060601 |
Dysphonia as first symptom of late-onset myasthenia gravis. | Journal of general internal medicine 20060601 |
Vincristine induced cranial polyneuropathy. | Indian journal of pediatrics 20060601 |
Multiple vaccine and pyridostigmine interactions: effects on EEG and sleep in the common marmoset. | Pharmacology, biochemistry, and behavior 20060601 |
[Myasthenia gravis and hyperthyroidism: two cases]. | Annales d'endocrinologie 20060601 |
Residual wires and autonomic failure treatment. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20060601 |
Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
Interaction of pyridostigmine bromide and N,N-diethyl-m-toluamide alone and in combination with P-glycoprotein expressed in Escherichia coli leaky mutant. | Journal of toxicology and environmental health. Part A 20060501 |
Myasthenia gravis accompanied with hypokalemic periodic paralysis. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060501 |
Pyridostigmine treatment trial in neurogenic orthostatic hypotension. | Archives of neurology 20060401 |
Fetal exposure to 3,4-diaminopyridine in a pregnant woman with congenital myasthenia syndrome. | The Annals of pharmacotherapy 20060401 |
Acetylcholinesterase inhibition and orthostatic hypotension. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20060401 |
Childhood sexual abuse in relation to neurobiological challenge tests in patients with borderline personality disorder and normal controls. | Psychiatry research 20060330 |
Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease. | International journal of cardiology 20060208 |
[Stopping smoking and constipation]. | Presse medicale (Paris, France : 1983) 20060201 |
Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning. | Journal of applied toxicology : JAT 20060101 |
[Ocular involvement in MuSK antibody-positive myasthenia gravis]. | Klinische Monatsblatter fur Augenheilkunde 20060101 |
Rapid determination of N,N-diethyl-m-toluamide and permethrin in human plasma by gas chromatography-mass spectrometry and pyridostigmine bromide by high-performance liquid chromatography. | Journal of analytical toxicology 20060101 |
Determination of pyridostigmine bromide and its metabolites in biological samples. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20060101 |
Circadian rhythms of heart rate and locomotion after treatment with low-dose acetylcholinesterase inhibitors. | Journal of applied toxicology : JAT 20060101 |
Myasthenia gravis disclosed by lithium carbonate. | The Journal of neuropsychiatry and clinical neurosciences 20060101 |
Intestinal pseudo-obstruction as initial presentation of thymoma. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20060101 |
Acetylcholinesterase inhibition affects cardiovascular structure in mice. | Physiological research 20060101 |
Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman. | Chemico-biological interactions 20051215 |
Bioscavengers for the protection of humans against organophosphate toxicity. | Chemico-biological interactions 20051215 |
Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicity. | Chemico-biological interactions 20051215 |
An ex vivo approach for the evaluation of reversible inhibitors as potential pretreatments against organophosphate toxicity. | Chemico-biological interactions 20051215 |
Pyridostigmine in the treatment of orthostatic hypotension. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20051201 |
Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG. | Neurology 20051108 |
Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome. | The Journal of clinical endocrinology and metabolism 20051001 |
Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment. | The British journal of ophthalmology 20051001 |
An elderly man with dysphagia and dysarthria. | Indian journal of medical sciences 20051001 |
Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis. | International journal of cardiology 20050901 |
Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil. | Neurology 20050823 |
Mild interoceptive stressors affect learning and reactivity to contextual cues: toward understanding the development of unexplained illnesses. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050801 |
Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. | Circulation 20050531 |
Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion. | Clinical endocrinology 20050501 |
Vaccination alone or in combination with pyridostigmine promotes and prolongs activation of stress-activated kinases induced by stress in the mouse brain. | Journal of neurochemistry 20050501 |
Off-label administration of drugs to healthy military personnel. Dubious ethics of preventive measures. | Journal of medical ethics 20050501 |
Low-dose cholinesterase inhibitors do not induce delayed effects on cerebral blood flow and metabolism. | Pharmacology, biochemistry, and behavior 20050401 |
Treatment counters low blood pressure upon standing. | Mayo Clinic health letter (English ed.) 20050401 |
Bifunctional compounds eliciting both anti-inflammatory and cholinergic activity as potential drugs for neuroinflammatory impairments. | Neuroscience letters 20050307 |
A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model. | International immunopharmacology 20050301 |
Pharmacologic prophylaxis against nerve agent poisoning. | The Israel Medical Association journal : IMAJ 20050301 |
Peripheral ChE inhibition modulates brain monoamines levels and c-fos oncogene in mice subjected to a stress situation. | Neurochemical research 20050301 |
Myasthenia gravis and a rare complication of chemotherapy. | The Medical journal of Australia 20050207 |
The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components. | Neurobiology of disease 20050201 |
Pyridostigmine for treatment of neurogenic orthostatic hypotension [correction of hypertension]--a follow-up survey study. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20050201 |
Do vasoactive neuropeptide autoimmune disorders explain pyridostigmine's association with Gulf War syndrome? | Medical hypotheses 20050101 |
Diagnosis of growth hormone deficiency. | Frontiers of hormone research 20050101 |
[The influence of aminostigmine on the parameters of nonspecific resistance and immune system of the organism upon acute poisoning of benzyl 3-quinuclidylate]. | Eksperimental'naia i klinicheskaia farmakologiia 20050101 |
Old legacies and new paradigms: confusing 'research' and 'treatment' and its consequences in responding to emergent health threats. | Journal of health care law & policy 20050101 |
Statin-associated exacerbation of myasthenia gravis. | Neurology 20041214 |
Cardiac responses of Pacific oyster Crassostrea gigas to agents modulating cholinergic function. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20041201 |
New treatment eyed for low blood pressure. | Harvard heart letter : from Harvard Medical School 20041201 |
An in vitro investigation of the effects of the nerve agent pretreatment pyridostigmine bromide on human peripheral blood T-cell function. | International immunopharmacology 20041101 |
Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia. | Heart (British Cardiac Society) 20041001 |
Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma. | American journal of hematology 20041001 |
Facile synthesis and initial PET imaging of novel potential heart acetylcholinesterase imaging agents [11C]pyridostigmine and its analogs. | Nuclear medicine and biology 20041001 |
Minimally invasive gastric bypass in a morbidly obese patient with myasthenia gravis. | Obesity surgery 20041001 |
Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. | Anaesthesia and intensive care 20041001 |
Pulmonary metastasis 12 years after resection of thymoma with microscopic capsule invasion. | Japanese journal of clinical oncology 20041001 |
The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. | The Journal of clinical endocrinology and metabolism 20040901 |
Sick veterans pin hopes on Gulf War inquiry. | Nature 20040819 |
Enhanced heart rate variability and baroreflex index after stress and cholinesterase inhibition in mice. | American journal of physiology. Heart and circulatory physiology 20040701 |
Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. | Autonomic neuroscience : basic & clinical 20040630 |
Distinct phenotypes of congenital acetylcholine receptor deficiency. | Neuromuscular disorders : NMD 20040601 |
Acetylcholine regulates ghrelin secretion in humans. | The Journal of clinical endocrinology and metabolism 20040501 |
Therapy for nerve agent poisoning. | Archives of neurology 20040501 |
Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity. | Toxicological sciences : an official journal of the Society of Toxicology 20040401 |
[Acute respiratory failure that needs mechanical ventilation: first manifestation of myasthenia gravis]. | Anales de medicina interna (Madrid, Spain : 1984) 20040401 |
Persistent/delayed toxic effects of low-dose sarin and pyridostigmine under physical stress (exercise) in mice. | Indian journal of physiology and pharmacology 20040401 |
Joint pain and hyperalgesia due to pyridostigmine bromide in a patient with myasthenia gravis. | Neurology 20040309 |
Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine. | Pediatric blood & cancer 20040301 |
Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome. | Clinical endocrinology 20040301 |
Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. | Archives of dermatology 20040301 |
Congenital myasthenic syndrome: presentation, electrodiagnosis, and muscle biopsy. | Journal of child neurology 20040301 |
Acute experimental tabun-induced intoxication and its therapy in rats. | Central European journal of public health 20040301 |
Does early treatment of ocular myasthenia gravis with prednisone reduce progression to generalized disease? | Journal of the neurological sciences 20040215 |
The effect of prednisone on the progression from ocular to generalized myasthenia gravis. | Journal of the neurological sciences 20040215 |
Co-exposure to pyridostigmine bromide, DEET, and/or permethrin causes sensorimotor deficit and alterations in brain acetylcholinesterase activity. | Pharmacology, biochemistry, and behavior 20040201 |
Lambert-Eaton myasthenic syndrome. | Revue neurologique 20040201 |
Effects of fosphenytoin on nerve agent-induced status epilepticus. | Drug and chemical toxicology 20040201 |
Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice. | Immunopharmacology and immunotoxicology 20040201 |
Stress and combined exposure to low doses of pyridostigmine bromide, DEET, and permethrin produce neurochemical and neuropathological alterations in cerebral cortex, hippocampus, and cerebellum. | Journal of toxicology and environmental health. Part A 20040123 |
Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. | Psychiatry research 20040101 |
Low-level exposure of guinea pigs and marmosets to sarin vapour in air: lowest-observable-adverse-effect level (LOAEL) for miosis. | Journal of applied toxicology : JAT 20040101 |
New approaches to the treatment of pemphigus. | The journal of investigative dermatology. Symposium proceedings 20040101 |
Acute neuromuscular failure related to long-term botulinum toxin therapy. | European neurology 20040101 |
Myasthenia gravis: an unusual cause of diplopia in polymyalgia rheumatica. | Clinical and experimental rheumatology 20040101 |
Low levels of sarin affect the EEG in marmoset monkeys: a pilot study. | Journal of applied toxicology : JAT 20040101 |
Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement. | Journal of neurology, neurosurgery, and psychiatry 20031201 |
Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of pyridostigmine bromide from guinea pig plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031105 |
Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats. | Archives of toxicology 20031001 |
Acetylcholinesterase inhibition in the treatment of hypotension. | Journal of neurology, neurosurgery, and psychiatry 20030901 |
Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. | Journal of neurology, neurosurgery, and psychiatry 20030901 |
Heart rate variability in chronic heart failure: target for therapy? | American heart journal 20030901 |
Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. | American heart journal 20030901 |
Unilateral headache due to myasthenia gravis. | Cephalalgia : an international journal of headache 20030901 |
Combined forced running stress and subclinical paraoxon exposure have little effect on pyridostigmine-induced acute toxicity in rats. | Toxicology 20030828 |
Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects. | Clinical science (London, England : 1979) 20030801 |
Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. | Heart (British Cardiac Society) 20030801 |
Childhood ocular myasthenia gravis. | Ophthalmology 20030701 |
Comparative efficacy of diazepam and avizafone against sarin-induced neuropathology and respiratory failure in guinea pigs: influence of atropine dose. | Toxicology 20030630 |
Gulf War syndrome revisited. | EMBO reports 20030601 |
Controlled intermittent asystole cardiac therapy induced by pharmacologically potentiated vagus nerve stimulation in normal and hibernating myocardium. | The Annals of thoracic surgery 20030601 |
Myasthenia gravis and masticatory muscle myositis in a dog. | The Canadian veterinary journal = La revue veterinaire canadienne 20030601 |
Parkinson's disease associated with myasthenia gravis. A report of 4 cases. | Journal of neurology 20030601 |
Prolonged treatment with glycerophosphocholine, an acetylcholine precursor, does not disclose the potentiating effect of cholinesterase inhibitors on GHRH-induced somatotroph secretion in anorexia nervosa. | Journal of endocrinological investigation 20030601 |
Stress interacts with peripheral cholinesterase inhibitors to cause central nervous system effects. | Life sciences 20030523 |
Take your pyridostigmine: that's an (ethical?) order! | The Lancet. Neurology 20030501 |
Control of nerve agent-induced seizures is critical for neuroprotection and survival. | Toxicology and applied pharmacology 20030415 |
Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency. | Clinical endocrinology 20030401 |
Changes in respiratory condition after thymectomy for patients with myasthenia gravis. | Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20030401 |
Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in tabun-poisoned rats. | Toxicology 20030314 |
Clinical trials. New rule triggers debate over best way to test drugs. | Science (New York, N.Y.) 20030314 |
Thymectomy in ocular myasthenia gravis. | The Journal of thoracic and cardiovascular surgery 20030301 |
Effect of chronic pyridostigmine bromide treatment on cardiovascular and behavioral parameters in mice. | Pharmacology, biochemistry, and behavior 20030301 |
Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin. | Toxicology 20030201 |
[Ogilvie's syndrome: a rare cause of the acute abdomen]. | Zeitschrift fur Gastroenterologie 20030201 |
Pyridostigmine enhances glutamatergic transmission in hippocampal CA1 neurons. | Experimental neurology 20030201 |
Impact of growth hormone on central nervous activity, vigilance, and tiredness after short-term therapy in growth hormone-deficient adults. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20030201 |
Percutaneous absorption of topical N,N-diethyl-m-toluamide (DEET): effects of exposure variables and coadministered toxicants. | Journal of toxicology and environmental health. Part A 20030124 |
Testicular germ-cell apoptosis in stressed rats following combined exposure to pyridostigmine bromide, N,N-diethyl m-toluamide (DEET), and permethrin. | Journal of toxicology and environmental health. Part A 20030110 |
Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women. | Psychoneuroendocrinology 20030101 |
Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors. | The Journal of pharmacology and experimental therapeutics 20030101 |
Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans. | Clinical endocrinology 20030101 |
Pyridostigmine for fibromyalgia: comment on the article by Paiva and a historical vignette. | Arthritis and rheumatism 20030101 |
Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies. | European neurology 20030101 |
Double trouble. | Survey of ophthalmology 20030101 |
Heightening awareness of myasthenia gravis, its presentation, symptoms and new treatments that are now available. | Journal of the Irish Dental Association 20030101 |
A comparison of the neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in soman-poisoned rats. | Acta medica (Hradec Kralove) 20030101 |
Effect of methoxime combined with anticholinergic, anticonvulsant or anti-HCN drugs in tabun-poisoned mice. | Acta medica (Hradec Kralove) 20030101 |
The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis. | Journal of postgraduate medicine 20030101 |
A typical case of Myasthenia Gravis. | Kathmandu University medical journal (KUMJ) 20030101 |
Intravenous immunoglobulin monotherapy in long-term treatment of myasthenia gravis. | Clinical neurology and neurosurgery 20021201 |
Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. | Anesthesia and analgesia 20021201 |
Autosomal recessive limb girdle myasthenia in two sisters. | Neurology India 20021201 |
Protein binding of isofluorophate in vivo after coexposure to multiple chemicals. | Environmental health perspectives 20021201 |
Myasthenia mimicking vertebrobasilar stroke. | Journal of neurology 20021101 |
In myasthenia gravis, clinical and immunological improvement post-thymectomy segregate with results of in vitro antibody secretion by immunocytes. | Journal of the neurological sciences 20021015 |
Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors. | Anesthesia and analgesia 20020901 |
Complete inhibition of hypothalamic somatostatin activity is only partially responsible for the growth hormone response to strenuous exercise. | Metabolism: clinical and experimental 20020901 |
Acute and repeated restraint stress have little effect on pyridostigmine toxicity or brain regional cholinesterase inhibition in rats. | Toxicological sciences : an official journal of the Society of Toxicology 20020901 |
Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig. | Neurotoxicology 20020901 |
Preparation and in vitro evaluation of pyridostigmine bromide microparticles. | International journal of pharmaceutics 20020821 |
A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. | Toxicology 20020815 |
Myasthenia gravis in pregnancy: report on 69 cases. | European journal of obstetrics, gynecology, and reproductive biology 20020805 |
Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin. Alone and in combination. | Toxicological sciences : an official journal of the Society of Toxicology 20020801 |
Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity. | Drug and chemical toxicology 20020801 |
Altered hypothalamic cholinergic responses in patients with nonulcer dyspepsia: a study of pyridostigmine-stimulated growth hormone release. | The American journal of gastroenterology 20020801 |
Neither forced running nor forced swimming affect acute pyridostigmine toxicity or brain-regional cholinesterase inhibition in rats. | Toxicology 20020701 |
Sensitivity to vecuronium in seropositive and seronegative patients with myasthenia gravis. | Anesthesia and analgesia 20020701 |
Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study. | Psychopharmacology 20020701 |
Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis. | Muscle & nerve 20020701 |
[Ptosis and mastication disorders revealing concurrent myasthenia gravis and chronic polyradiculoneuritis]. | Revue neurologique 20020701 |
Pyridostigmine bromide modulates the dermal disposition of [14C]permethrin. | Toxicology and applied pharmacology 20020615 |
[Growth disorders in Down's syndrome: growth hormone treatment]. | Minerva endocrinologica 20020601 |
Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20020601 |
Pyridostigmine bromide and the long-term subjective health status of a sample of over 700 male Reserve Component Gulf War era veterans. | Psychological reports 20020601 |
Actions of pyridostigmine and organophosphate agents on chick cells, mice, and chickens. | Drug and chemical toxicology 20020501 |
Binding of pyridostigmine bromide, N,N-diethyl-m-toluamide and permethrin, alone and in combinations, to human serum albumin. | Archives of toxicology 20020501 |
Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. | Arthritis and rheumatism 20020501 |
In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamide. | Drug metabolism and disposition: the biological fate of chemicals 20020301 |
Sensorimotor deficit and cholinergic changes following coexposure with pyridostigmine bromide and sarin in rats. | Toxicological sciences : an official journal of the Society of Toxicology 20020301 |
Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa. | Clinical endocrinology 20020301 |
Pyridophens: binary pyridostigmine-aprophen prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors. | Journal of medicinal chemistry 20020214 |
Peripheral cholinergic pathway modulates hyperthermia induced by stress in rats exposed to open-field stress. | Journal of applied physiology (Bethesda, Md. : 1985) 20020201 |
Presentation of myasthenia gravis mimicking blepharospasm. | Neurology 20020108 |
Prevention and treatment of injury from chemical warfare agents. | The Medical letter on drugs and therapeutics 20020107 |
The use of the pyridostigmine growth hormone-releasing hormone stimulation test to detect growth hormone deficiency in patients with pituitary adenomas. | Metabolism: clinical and experimental 20020101 |
Ocular myasthenia presenting as progressive external ophthalmoplegia. | Journal of pediatric ophthalmology and strabismus 20020101 |
Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases. | Binocular vision & strabismus quarterly 20020101 |
Cardiorespiratory effects following acute exposure to pyridostigmine bromide and/or N,N-diethyl-m-toluamide (DEET) in rats. | International journal of toxicology 20020101 |
[Respiratory arrests caused by congenital myasthenia gravis syndrome]. | Duodecim; laaketieteellinen aikakauskirja 20020101 |
Determination of physostigmine and pyridostigmine in pharmaceutical formulations by capillary electrophoresis. | Journal of capillary electrophoresis and microchip technology 20020101 |
A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine. | Journal of pharmaceutical and biomedical analysis 20011201 |
Effects of contralateral white noise stimulation on distortion product otoacoustic emissions in myasthenic patients. | Hearing research 20011201 |
Side effects of low-dose pyridostigmine bromide are not related to cholinesterase inhibition. | Aviation, space, and environmental medicine 20011201 |
The effect of continuous pyridostigmine administration on functional (A12) acetylcholinesterase activity in guinea-pig muscles. | Neurotoxicology 20011201 |
Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats. | Liver 20011201 |
Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour. | Journal of applied toxicology : JAT 20011201 |
Reactive oxygen species mediate pyridostigmine-induced neuronal apoptosis: involvement of muscarinic and NMDA receptors. | Toxicology and applied pharmacology 20011115 |
Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels. | The Journal of clinical endocrinology and metabolism 20011101 |
Determination of depleted uranium, pyridostigmine bromide and its metabolite in plasma and urine following combined administration in rats. | Journal of pharmaceutical and biomedical analysis 20010901 |
The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion. | Environmental toxicology and chemistry 20010901 |
Electroplegia: an alternative to blood cardioplegia for arresting the heart during conventional (on-pump) cardiac operation. | The Annals of thoracic surgery 20010901 |
Myasthenia gravis in children: analysis of 18 patients. | Arquivos de neuro-psiquiatria 20010901 |
Combined exposure to sarin and pyridostigmine bromide increased levels of rat urinary 3-nitrotyrosine and 8-hydroxy-2'-deoxyguanosine, biomarkers of oxidative stress. | Toxicology letters 20010806 |
High-performance liquid chromatographic determination of pyridostigmine bromide, nicotine, and their metabolites in rat plasma and urine. | Journal of chromatographic science 20010701 |
Pyridostigmine-induced microcephaly. | Neurology 20010612 |
Pyridostigmine-induced microcephaly. | Neurology 20010612 |
Evaluation of immunotoxicity induced by single or concurrent exposure to N,N-diethyl-m-toluamide (DEET), pyridostigmine bromide (PYR), and JP-8 jet fuel. | Toxicology and industrial health 20010601 |
Myasthenia gravis with autoimmune autonomic neuropathy. | Autonomic neuroscience : basic & clinical 20010514 |
Subchronic administration of various pretreatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability. | Drug and chemical toxicology 20010501 |
Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity. | Drug and chemical toxicology 20010501 |
Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome. | Journal of endocrinological investigation 20010501 |
Induction of urinary excretion of 3-nitrotyrosine, a marker of oxidative stress, following administration of pyridostigmine bromide, DEET (N,N-diethyl-m-toluamide) and permethrin, alone and in combination in rats. | Toxicology letters 20010430 |
Chromatographic method for the determination of diazepam, pyridostigmine bromide, and their metabolites in rat plasma and urine. | Journal of chromatography. B, Biomedical sciences and applications 20010425 |
Development of a high-performance liquid chromatographic method for the quantification of chlorpyrifos, pyridostigmine bromide, N,N-diethyl-m-toluamide and their metabolites in rat plasma and urine. | Journal of chromatography. B, Biomedical sciences and applications 20010425 |
Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. | Toxicological sciences : an official journal of the Society of Toxicology 20010401 |
Analysis of thymectomy for myasthenia gravis in older patients: a 20-year single institution experience. | Journal of the American College of Surgeons 20010401 |
Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine. | Arquivos brasileiros de cardiologia 20010401 |
Familial autoimmune myasthenia gravis. | Singapore medical journal 20010401 |
Cocaine abuse, generalized myasthenia, complete external ophthalmoplegia, and pseudotonic pupil. | Strabismus 20010301 |
Central nervous system effects from a peripherally acting cholinesterase inhibiting agent: interaction with stress or genetics. | Annals of the New York Academy of Sciences 20010301 |
Laryngeal myasthenia gravis: report of 40 cases. | Journal of voice : official journal of the Voice Foundation 20010301 |
Pyridostigmine bromide and the long-term subjective health status of a sample of female reserve component Gulf War veterans: a brief report. | Psychological reports 20010201 |
Perioperative management of a patient with congenital myasthenia gravis for elective caesarean section. | Singapore medical journal 20010201 |
Many Gulf War illnesses may be autoimmune disorders caused by the chemical and biological stressors pyridostigmine bromide, and adrenaline. | Medical hypotheses 20010201 |
Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society 20010201 |
Viral neuroinvasion as a marker for BBB integrity following exposure to cholinesterase inhibitors. | Life sciences 20010119 |
A dose-response study of anticholinesterase drugs on contractile and phosphatidylinositol responses of rat trachea. | Anesthesia and analgesia 20010101 |
Biological consequences of multiple vaccine and pyridostigmine pretreatment in the guinea pig. | Journal of applied toxicology : JAT 20010101 |
Bulbar presentations of myasthenia gravis in the elderly patient. | The Journal of laryngology and otology 20010101 |
The effects of pyridostigmine bromide on progressive ratio performance in male and female rats. | Pharmacology, biochemistry, and behavior 20010101 |
The role of cholinergic transmission in outer hair cell functioning evaluated by distortion product otoacoustic emissions in myasthenic patients. | Acta oto-laryngologica 20010101 |
The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis. | Clinical neuropharmacology 20010101 |
The effects of pyridostigmine bromide, permethrin, and DEET alone, or in combination, on fixed-ratio and fixed-interval behavior in male and female rats. | Pharmacology, biochemistry, and behavior 20010101 |
Interaction of pyridostigmine and physical stress on antioxidant defense system in skeletal muscle of mice. | Journal of applied toxicology : JAT 20010101 |
[Myasthenia gravis associated with HIV infection]. | Ryoikibetsu shokogun shirizu 20010101 |
The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternation performance in rats. | Pharmacology, biochemistry, and behavior 20010101 |
Prognostic factors of thymectomy in patients with myasthenia gravis: a cohort of 132 patients. | European neurology 20010101 |
Neurotoxicology of the brain barrier system: new implications. | Journal of toxicology. Clinical toxicology 20010101 |
Ritonavir-associated myasthenia gravis. | Muscle & nerve 19980501 |
[Myasthenic crisis caused by azathioprine-induced fever]. | Der Nervenarzt 19970401 |
Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli. | The Journal of clinical endocrinology and metabolism 19960301 |
Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. | The Journal of clinical endocrinology and metabolism 19960301 |
Myasthenia gravis and levonorgestrel implant. | Lancet (London, England) 19951209 |
Myasthenia gravis following iron chelation therapy with intravenous desferrioxamine. | European journal of haematology 19950801 |
D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence? | Clinical rheumatology 19941201 |
[D-penicillamine-induced myasthenia gravis]. | Schweizerische medizinische Wochenschrift 19940521 |
Influence of endogenous cholinergic tone and alpha-adrenergic pathways on growth hormone responses to His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in the dog. | The Journal of endocrinology 19930801 |
Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. | The Journal of clinical endocrinology and metabolism 19930401 |
[A comparison of the two anticholinergic agents atropine and glycopyrrolate during antagonism of a muscle relaxation with pyridostigmine]. | Anaesthesiologie und Reanimation 19930101 |
Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. | The Journal of clinical endocrinology and metabolism 19930101 |
Myasthenia gravis presenting as weakness after magnesium administration. | Muscle & nerve 19900801 |
Long term treatment of myasthenia gravis with azathioprine. | Postgraduate medical journal 19900201 |
Prolonged paralysis associated with long-term pancuronium use. | Pharmacotherapy 19890101 |
Parkinsonism induced by pyridostigmine. | Acta neurologica Scandinavica 19880901 |
[Acetylcholine receptor antibody in D-penicillamine therapy]. | Zeitschrift fur Rheumatologie 19860101 |
[Hemodynamic effects in antagonism of neuromuscular blockage: atropine-pyridostigmine versus ipratropium bromide-pyridostigmine]. | Der Anaesthesist 19841001 |
Penicillamine induced myasthenia reactivated by gold. | British medical journal (Clinical research ed.) 19840121 |
[Myasthenic syndrome--complication of D-penicillamine therapy]. | Zeitschrift fur arztliche Fortbildung 19840101 |
D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis. | Gastroenterology 19840101 |
[Myasthenia syndrome during chloroquine treatment (author's transl)]. | Deutsche medizinische Wochenschrift (1946) 19811225 |
Myasthenia gravis and penicillamine therapy of rheumatoid arthritis. | JAMA 19801017 |
Timolol and myasthenia gravis. | JAMA 19791012 |
[A myasthenic reaction provoked by lithium carbonate treatment]. | Ugeskrift for laeger 19780925 |
[Myasthenia syndrome after peroral treatment with penicillamine]. | Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 19780101 |
D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis. | Annals of internal medicine 19771101 |
Cardiac arrest and arrhythmias due to self-poisoning with imipramine. | Anaesthesia 19690101 |
© 2019 Angene International Limited. All rights Reserved.